Notification No 56/2015-2020 Dated. 24thFebruary, 2022
Issued By. DGFT
Subject : Amendment in Export Policy of Remdesivir Injection and API, Amphotericin-B Injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) – regarding
*****
The Central Government has made amendment in the export policy of Remdesivir Injection and API, Amphotericin-B Injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) as below :-
| Sl No | ITC HS Code | Description | Present Policy | Revised Policy |
| 207 AA | Ex 293499 Ex 300490 | Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) | Restricted | Free |
| 207 AB | Ex 30049029 Ex 30049099 | Amphotericin – B Injections | ||
| 207 AE | Ex 2942 Ex 3001 | Enoxaparin (Formulation and API) | ||
| 207 AF | Ex 3002 | Intra-Venous Immunoglobulin (IVIG) (Formulation and API) |
Analysis
| Sl No | Particulars | Remarks |
| 01 | Effect of the Notification | The export policy of Injection Remdesivir and Remdesivir API, Amphotericin – B injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) falling under HS code as mentioned above or falling under any other HS code has been made ‘Free’ with immediate effect. |